Skip to main content
. 2012 Apr 11;35(5):1119–1125. doi: 10.2337/dc11-2050

Table 1.

Weight, fasting plasma lipids, and measures of β-cell function, insulin sensitivity, and glucose tolerance before and at the end of treatment with colesevelam

graphic file with name 1119tbl1.jpg

HHS Vulnerability Disclosure